--- type: "Topics" locale: "en" url: "https://longbridge.com/en/topics/100000000650096.md" description: "$Hims & Hers Health(HIMS.US) | ๐‡๐ข๐ฆ๐ฌ & ๐‡๐ž๐ซ๐ฌ: Canaccord maintains ๐๐ฎ๐ฒ, raises ๐๐“ ๐ญ๐จ $๐Ÿ‘๐ŸAnalyst sees $Novo Nordisk AS(NVO.US) Novo partnership and strong subscriber momentum driving 2H growth acceleration despite near-term margin pressure." datetime: "2026-05-12T10:57:55.000Z" locales: - [en](https://longbridge.com/en/topics/100000000650096.md) - [zh-CN](https://longbridge.com/zh-CN/topics/100000000650096.md) - [zh-HK](https://longbridge.com/zh-HK/topics/100000000650096.md) author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)" generator: "portal-rs" --- # $Hims & Hers Health(HIMS.US) | ๐‡๐ข๐ฆ๐ฌ & ๐‡๐ž๐ซ๐ฌโ€ฆ ### Related Stocks - [NVO.US](https://longbridge.com/en/quote/NVO.US.md) - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**